EBITDA every 5 years. Indorama Ventures 1st Quarter 2019 MD&A 11 Forward-looking Statements The statements included herein contain “forward-looking statements” of Indorama Ventures Public Company Limited
remain confident to double our EBITDA every 5 years. Indorama Ventures 1st Quarter 2019 MD&A 11 Forward-looking Statements The statements included herein contain “forward-looking statements” of Indorama
expected to remain on plan. Indorama Ventures 2nd Quarter 2019 MD&A 13 Forward-looking Statements The statements included herein contain “forward-looking statements” of Indorama Ventures Public Company
Cost per ASK excluding fuel cost 2.89 2.67 2.84 2.68 RASK – CASK (0.55) (0.32) (0.08) 0.15 Remarks (1) These figures are different from those included in Company’s consolidated Financial Statements as
3.36 3.35 3.36 Cost per ASK excluding fuel cost 2.67 2.75 2.68 2.72 RASK – CASK (0.32) (0.44) 0.15 (0.02) Remarks (1) These figures are different from those included in Company’s consolidated Financial
per ASK excluding fuel cost 2.69 2.91 2.67 2.77 RASK – CASK 0.03 (0.16) 0.12 (0.06) Remark (1) These figures are different from those included in Company’s consolidated Financial Statements as they
0.29 3.08 Net profit (loss) (0.07) 0.19 11.58 * Other income included revenue from sales of finished products, packages, packaging services, interest income and gain on disposal of assets. Statements of
income included revenue from sales of finished products, packages, packaging services, interest income and gain on disposal of assets. บริษัท ดีโอดี ไบโอเทค จ ำกัด (มหำชน) 111 หมู่ท่ี 2 ต ำบลท่ำจนี อ ำเภอ
fundamentals which should be included in individual CRA codes of conduct, and the elements contained in the IOSCO CRA Code should receive the full support of CRA management and be backed by thorough compliance